Intrexon Corp. is 10% at ZIOPHARM ONCOLOGY INC (ZIOP). They have made 15 open-market trades across 8 companies since 2011, most recently 2019-12-13.
13 open-market purchases totalling $94.1M since 2011, against 2 sales. Across 11 scored buys the stock is down 7.8% at ninety days, and 8.7 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 9% | 27% | 18% |
| Avg Move | -22.6% | -0.8% | -7.8% |
| Alpha | -19.4% | -1.8% | -8.7% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SYN | SELL | 2019-04-01 | 2019-04-03 | $0.66 | $99K | N/A | N/A | N/A |
| HSGX | SELL | 2019-01-11 | 2019-01-15 | $0.16 | $275K | -7.4% | -10.6% | +41.6% |
| AQB | BUY | 2018-01-17 | 2018-01-19 | $3.25 | $10.0M | -4.5% | -11.5% | +12.8% |
| FCSC | BUY | 2017-12-11 | 2017-12-13 | $0.77 | $4.2M | -5.9% | +8.6% | -13.8% |
| AQB | BUY | 2017-01-18 | 2017-01-20 | $10.33 | $25.0M | -45.4% | -33.9% | -63.0% |
| OGEN | BUY | 2016-06-30 | 2016-07-05 | $0.52 | $2.4M | +11.5% | +30.0% | -20.6% |
| APHB | BUY | 2015-03-16 | 2015-03-18 | $0.17 | $2.4M | -29.1% | +3.0% | +3.0% |
| ZIOP | BUY | 2015-02-09 | 2015-02-10 | $8.75 | $12.6M | -29.4% | -0.6% | -0.6% |
| SYN | BUY | 2013-12-17 | 2013-12-19 | $1.00 | $2.5M | N/A | N/A | N/A |
| ZIOP | BUY | 2013-10-29 | 2013-10-31 | $3.50 | $10.0M | -29.4% | -0.6% | -0.6% |
| OGEN | BUY | 2013-09-30 | 2013-10-02 | $3.00 | $7.9M | -28.0% | -1.4% | -1.4% |
| ORNI | BUY | 2012-07-31 | 2012-08-02 | $1.50 | $1.3M | N/A | N/A | N/A |
| ZIOP | BUY | 2011-08-23 | 2011-08-25 | $4.99 | $191K | -29.4% | -0.6% | -0.6% |
| ZIOP | BUY | 2011-08-05 | 2011-08-09 | $4.78 | $4.0M | -29.4% | -0.6% | -0.6% |
| ZIOP | BUY | 2011-01-12 | 2011-01-14 | $4.80 | $11.6M | -29.4% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| SYN |
| 165,332 |
| — |
| Total | $204.3M |
Shares reported on the most recent Form 4, priced at the 2019-12-17 close. 2 holdings could not be priced and are excluded from the total.